The disruption of genes by balanced translocations and other rare germline chromosomal abnormalities has played an important part in the discovery of many common Mendelian disorder genes, somatic oncogenes and tumour supressors. A search of published literature has identified 15 genes whose genomic sequences are directly disrupted by translocation breakpoints in individuals with neuropsychiatric illness. In these cases, it is reasonable to hypothesise that haploinsufficiency is a major factor contributing to illness. These findings suggest that the predicted polygenic nature of psychiatric illness may not represent the complete picture; genes of large individual effect appear to exist. Cytogenetic events may provide important insights into neurochemical pathways and cellular processes critical for the development of complex psychiatric phenotypes in the population at large.
THE GENETIC CONTRIBUTION TO PSYCHIATRIC ILLNESS IS COMPLEX
Twin and family studies have made it abundantly clear that powerful genetic risk factors act in concert with environmental factors to give rise to psychiatric illnesses such as schizophrenia, bipolar affective disorder and unipolar depression. 1 However, the precise nature of this contribution is not well understood. The number of genes contributing to illness susceptibility has yet to be defined either at the individual or population levels and considerable debate remains as to whether 'oligogenic' or 'polygenic' is the most accurate term for these disorders. Moreover, at the level of a hypothetical causative gene, it is not certain whether a single mutation or multiple independent mutations (allelic heterogeneity) will be found in the case population. 2 After a period of confusing and unreplicated results, the principal methodologies used to explore this genetic contribution, namely family linkage studies and case-control association studies, have begun to yield promising findings. The rather vaguely defined chromosome loci identified as housing risk factors have now, with the advent of the Human Genome Project data, been translated into a number of candidate genes. These include neuregulin (NRG1), dysbindin (DTNBP1), G72, COMT and RGS4 (recently reviewed in O'Donovan et al 3 and Harrison and Weinberger 4 ). All these are potentially interesting functional candidates, but their involvement in psychiatric illness has yet to be confirmed. Biased distributions of single-nucleotide polymorphisms (SNPs), or groups of SNPs (haplotypes), have been observed for the genes in case-control studies.
However, these polymorphisms are unlikely to be the actual disease-causing mutations but rather present in linkage disequilibrium with them. In only one instance, the ZDHHC8 gene, has an associated SNP been shown to have a defined effect on gene function. 5 In addition, there are marked differences between studies in the details of the associated markers or haplotypes implying allelic heterogeneity at individual gene loci: particularly between different geographical populations, as is the case in simple Mendelian disorders.
In summary, the detection of pathological gene mutations lags behind the identification of candidate genes and chromosomal loci in psychiatric illnesses.
CYTOGENETICS AS A TOOL FOR HUNTING DISEASE GENES
In the last half-century human cytogenetics has emerged as a distinct discipline following the discovery of the number and form of the human chromosomal complement. [6] [7] [8] Within the last decade, it has become possible to translate chromosome position into annotated genomic DNA sequence allowing cytogenetics to proceed from an observational science to a diagnostic tool and, more recently, a direct means to isolate disease genes.
The advantage of a cytogenetic approach to disease gene identification in the postgenomic era is that the chromosome abnormality is both the physical 'flag' by which the candidate gene can be speedily identified and the functional mutation itself.
The rarity of these cases is perhaps their biggest drawback to the investigator. Discrete cytogenetic abnormalities, in contrast to numerical chromosomal anomalies such as trisomies, are rarely found in association with complex disorders such as schizophrenia and the affective disorders. The reason for this rarity becomes clear when the factors involved are considered: the prevalence and the number of genes that can give rise to the disorder, the frequency of chromosome abnormalities in the population, the size of the human genome, the size of the gene loci themselves and the efficiency of clinical ascertainment. Assuming an average gene size of 27 kb, 9 a genome size of 3 billion bases, two breakpoints per chromosome abnormality (eg a typical reciprocal translocation/inversion) and a frequency of such abnormalities in the population of 0.29-0.56% 10, 11 then, providing the disruption is compatible with life, any given gene would be cytogenetically disrupted in 3-6 individuals in the UK population of B60 million. However, for any specific locus this is probably an underestimate because breakpoints are unlikely to occur as a truly random phenomenon.
Naturally, such opportunities have been exploited by human geneticists. A combination of positional evidence from linkage studies and the analysis of rare cytogenetic lesions in patients has led to the discovery of the underlying genetics of Duchenne muscular dystrophy, retinoblastoma, neurofibromatosis type 1, Wilms tumour, tuberous sclerosis, polycystic kidney disease, aniridia, familial polyposis coli and fragile-X syndrome among others. The rate of such abnormalities may still be underestimated within a given condition, especially when those previously cryptic to standard microscopic methods are included. In a recent study of aniridia, 30 of 77 patients studied were found to have a variety of chromosomal abnormalities including deletions and translocations around the Wilms tumour locus on 11p. 12 In addition to the germline chromosome rearrangements described above, somatic rearrangements in tumours and leukaemias have aided the identification of many new oncogenes and tumour suppressors. 13 Although a full description is outside the remit of this review, several models have been put forward to explain the mechanistic basis of translocation events. These suggest that either particular chromosomal motifs, for example, low copy repeats, or AT-rich palindromes or, alternatively, the physical properties of the DNA sequences increase the risk of architectural rearrangements. [14] [15] [16] [17] [18] [19] [20] Different explanations are likely to be required for random (unique) or conserved (recurrent) rearrangements.
THE SCOPE OF THE REVIEW
This review focuses on psychiatric disorders and is limited to those cases where apparently simple events, translocations, inversions or insertions, have been shown to disrupt a gene between the first and last exons. Many other examples exist of abnormalities where the breakpoint lies outside the coding portion of the bona fide disease gene (by up to 1 Mb in some cases) but still perturbs function through a position effect or the separation of enhancer elements from the promoter. [21] [22] [23] However, these instances have required considerable confirmatory experimentation. For similar reasons, we have not included the contribution of cytogenetics to important neurological associates such as mental retardation (UK equivalent terminology is learning disability), dup15 (associated with joint laxity and panic disorder) or genomic disorders that are associated with clear behavioural phenotypes such as Williams syndrome (overfriendliness and anxiety), Smith-Magenis syndrome (self-injury), Prader-Willi syndrome (hyperphagia) or chromosome 22 deletion syndrome (associated with psychosis). [24] [25] [26] [27] [28] Neither shall we discuss the important work being carried out on the phenomenon of subtelomeric deletions associated with idiopathic mental retardation 29, 30 as well as autism.
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The purpose of the selection in this review is to collate and describe the function of genes where one parental copy is definitively damaged and most likely nonfunctional in a patient with a major mental disorder.
The phenotypes covered in this review have been loosely grouped under the term 'neuropsychiatric' conditions or 'functional' disorders with particular emphasis on mental health and cognitive function. A list of the 15 genes identified by this strategy together with their various functions and properties is presented in Table 1 . Three of these genes have been identified in our laboratory in the course of a detailed molecular characterisation of over 12 chromosomal rearrangements in individuals with psychiatric illness (principally schizophrenia). The majority of cases 'Association' column, indicates if a published association study exists; 'Result' column, association study result where carried out; Sugg., suggestive positive association; MR, mental retardation; OCD, obsessivecompulsive disorder, BPAD, bipolar affective disorder.
We have collated information on 15 disrupted genes matching the criteria described above. These genes were found using PubMed 60 literature searches using the following text queries singly or combined: 'psychiatric illness', 'schizophrenia', 'bipolar affective disorder', 'autism', 'chromosome abnormality', 'translocation', 'breakpoint' and 'cytogenetics'. Overall, the described experimental strategies employed to progress from abnormality to gene principally involved fluorescence in situ hybridisation (FISH) coupled, in some instances, with Southern-based fine mapping of breakpoints. One gene, SSBP1, was promoted to the class of disrupted genes by the identification by the authors of this review, in recently annotated genome sequence releases, of 3 0 splice variants spanning the breakpoint. References in bold are the primary gene identification papers. studied possessed direct gene disruptions or breakpoints close to good candidate genes, which suggests that the chromosomal rearrangements are the underlying cause of the psychiatric conditions in these individuals. In this article, we aim to identify common themes linking the function of individual genes whose disruptions, albeit extremely rare events, may give clues about the cellular processes and neurochemical pathways critical to complex psychiatric phenotypes.
CHANCE FINDINGS OR CAUSAL EVENTS?
When considering the biological significance of these data, we must ask if the chromosomal abnormalities and disrupted genes observed are chance findings or causal to the phenotypes of the carriers. Support for a causal involvement in the disorder can be provided by establishing significant linkage between the chromosome abnormality and illness in an extended family. Unfortunately, to date, access to necessarily large pedigrees has been restricted to the t(1;11) family in which DISC1 is disrupted (see 'carriers' column in Table 1 ). In this case, an LOD score of 7.1 confirmed linkage between the translocation and illness in this family. 61 Alternatively multiple independent observations of a rearrangement affecting a particular gene as reported for SATB2 in cleft palate would be good evidence of its involvement. 62 Owing to the large number of genes presumably involved and the small number of reported rearrangements, it is perhaps not surprising that independent reports of disruptions to the same gene have yet to be reported for neuropsychiatric conditions. However, this also means that we have not yet fully exploited cytogenetics as a gene-finding approach.
It is important to investigate whether these disrupted genes are unique, case-specific, findings or whether they contribute more widely to illness in the general population by alternative mutation mechanisms, as was found to be the case for Duchenne muscular dystrophy and retinoblastoma.
A proportion of these disrupted genes may be unique representing a set of genes with the potential when mutated to cause disease but not represented by mutations at the population level. Studies to detect linkage disequilibrium between disease-and gene-related polymorphisms in the general population have been performed in a number of the instances as detailed in Table 1 , but statistically robust association studies have not been carried out for all of these genes to assess their population attributable risk.
PHENOTYPES OF TRANSLOCATION CARRIERS
In major psychiatric disorders, there is often variable penetrance and a spectrum of phenotypes within a family. The t(1;11) family segregates for both schizophrenia and affective psychosis, for example. Such pleiomorphic phenotypes are increasingly being described within monogenic conditions and also for chromosomal deletions with relatively stable disruption boundaries such as the chromosome 22 deletion syndrome. Mouse studies have replicated this variability, ascribed largely to genetic modifiers elsewhere in the genome. 63 There are more cases of schizophrenia, autism and asperger syndrome in Table 1 than bipolar disorder and unipolar depression. In a recently collated list of published chromosome abnormalities associated with psychiatric illness, few of which have been studied at the molecular level, 22 cases match our criteria for selection based on phenotype and rearrangement type. 64 Of these, diagnoses of schizophrenia and related conditions occurred far more commonly than bipolar/unipolar disorders. Moreover, a network of Scandinavian cytogenetics laboratories has compiled data summarising 71 739 postnatal cytogenetic tests, of which 216 showed balanced chromosome rearrangements. 65 Of these, five were associated with psychotic mental illness and three with autism. We have also observed a similar diagnostic bias in unpublished cytogenetic cases under study in our laboratory. The reasons for this observed bias are not clear but there are two strong possibilities. There could be an ascertainment bias due to the more frequent referral of patients with schizophrenia or autism for cytogenetic analysis and greater resources for research into those disorders. The bias may also be due to the underlying genetic aetiology of these conditions. We predict that most instances of direct disruption will result in a decrease in transcription of the gene rather than the production of transcripts encoding aberrant forms of the protein because these would be liable to degradation by nonsense-mediated decay. We can postulate that schizophrenia and autism, in contrast to bipolar affective disorder or unipolar depression, are more frequently associated with gene haploinsufficiency. By analogy, a simple view of cancer-causing gene mutations is that they fall into two groups: gain-of-function in the case of oncogenes and loss-of-function in the case of tumour suppressor genes. Indeed, a derived classification of susceptibility genes into 'psychogenes' and 'psychosis suppressor' genes has already been proposed for psychiatric conditions. 66 Therefore, cytogenetics may help to identify the 'suppressor' type of gene implicated in the aetiology of a subset of neuropsychiatric conditions. Three cases in Table 1 are patients with mental retardation comorbid with autism, schizophrenia or bipolar disorder. Individuals with mental retardation are more likely to have psychiatric illness than the general population 67 and to have a contiguous gene syndrome, resulting from the hemizygous loss or gain of several genes simultaneously through microdeletions and duplications. However, Table 1 has included cases where the genetic lesion appears precisely limited to one gene and yet mental retardation still exists. One explanation might be that the gene has pleiotropic action, causing a neuropsychiatric disorder and, independently, mental retardation. Alternatively, gene disruption may have a greater effect on gene expression, giving rise to a more severe form of illness than a point mutation in a karyotypically normal patient.
COMMON THEMES IN GENE FUNCTION
With the caveat that it is relatively easy to propose a model placing a candidate gene at the heart of the presumed pathophysiology of psychosis when independent knowledge of the underlying biology is limited, there are some general and specific features of several genes described in Table 1 to support their role in the psychoses.
It is interesting that a glutamate receptor, GRIA3, is present within the list. The glutamate hypothesis, primarily applied to schizophrenia and related psychoses, was initially based on the observation that administration of phencyclidine and ketamine, antagonists of the NMDA subtype of glutamate receptor, can produce schizophrenia-like states. 68 The hypothesis has been strengthened by recent functional and behavioural data from transgenic knockdown experiments on an NMDA receptor gene (Grin1) in mice. 69 Loss-offunction mutants of glutamate receptors by cytogenetic disruption might be expected to have similar phenotypes.
Overall, with the exception of the two receptors, GRIA3 and GRPR, it is possible to group the candidates loosely into a class of genes encoding proteins involved in processes with multiple inputs (substrates, interacting proteins, DNA-binding sites) or outputs (products, interacting proteins, transcriptionally regulated genes). NBEA, CNTNAP2, DYX1C1 and DISC1 proteins may all mediate interactions with other proteins, perhaps participating in the formation of localised functional complexes. The three DNA-binding proteins, NPAS3, SSBP1 and FOXP2, are likely to have many targets. The proteasome complex component, USP6, the mitochondrial peptidase, IMMP2L, and the two enzymes within the N-linked glycosylation pathway, discussed in more detail below, are also examples of proteins with many potential substrates. It can be predicted that mutation of such focal points or 'hubs' of activity within a 'scale-free' biological network will be particularly harmful to cellular activity and function. 70, 71 RARE DISRUPTIONS MAY SIGNPOST COMMON AETIOLOGIES The goal of identifying genes from rare breakpoints is to understand the biological processes and pathways underlying the common forms of the disorder and to identify other constituent genes that show a measurable effect in the general population.
An example of breakpoints uncovering a common pathway comes with the identification of MGAT5 and DIBD1 as disrupted genes in schizophrenia comorbid with mental retardation and bipolar affective disorder, respectively. These two genes participate in N-linked glycosylation, a post-translational process involving the modification of secreted and membrane proteins through the addition of oligosaccharide moieties. Several other genes in this pathway have been shown to be causative for a varied group of disorders collectively known as congenital disorders of glycosylation or CDGs. 72, 73 These, predominantly recessive, disorders are often characterised by central nervous system phenotypes, suggesting that the brain is particularly susceptible to perturbations in protein glycosylation. 74 With a large set of target proteins predicted to be affected by these disorders, it is not hard to see how N-linked glycosylation enzymes might act as modifiers of other gene defects. Indeed, within the CDGs themselves, interactions of mutant genes have been shown to modulate the severity and nature of disease. Recently, another glycosylation enzyme, B3GAT1, was identified near to, but not directly disrupted by, a breakpoint in a family with schizophrenia-like psychosis and a t(6;11)(q14.2;q25) translocation. The proposed association has been complicated by the emergence of another gene transcript, FLJ37762, between this gene and the 11q25 breakpoint.
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DISC1 AS A MODEL FOR FUNCTIONAL AND GENETIC ANALYSES DISC1 was identified as a likely genetic risk factor for psychiatric illness from studies of a single large Scottish family multiply affected with severe psychiatric illness, including schizophrenia and affective disorders. In this family, a balanced (1;11)(q42;q14) translocation cosegregates with psychosis, generating a highly significant maximum LOD score of 7.1. 61, 76 Thus, in this family, translocation-induced gene disruption is causal, and a genetic locus of major effect is responsible for the psychosis in family members. On chromosome 1, the translocation directly disrupts two overlapping genes, DISC1 and DISC2, and it is therefore likely that altered expression of DISC1 and/or DISC2 underlies disease pathology in translocation carriers. 53, 77 The DISC region has subsequently been highlighted as a likely susceptibility locus for psychiatric illness by a number of independent genetic studies, with the most significant results generated by analysis of individuals diagnosed with schizophrenia in Finland. A genome-wide linkage study and subsequent follow-up studies using dense marker sets identified a peak of linkage with a polymorphism that lies within DISC1 itself, with a maximum LOD score of 3.2. 78 Several associated haplotypes have been identified within the same population. 79 Other reports of linkage to this region include studies of North American, Taiwanese, British and Icelandic families diagnosed variously with schizophrenia and affective disorders. [80] [81] [82] Both of these clinical phenotypes are expressed in the family segregating for the translocation. The DISC locus, although initially identified as a major risk factor only in a single family, is now emerging as a susceptibility locus for schizophrenia and affective disorders in several different populations.
Little is known of DISC1 and DISC2 function. Most studies have focused upon DISC1 and all information to date indicates an important role for this protein in the adult and foetal central nervous system. In particular, DISC1 is expressed in the hippocampus and limbic regions of the adult brain 83 and its possible involvement in neurodevelopmental processes has been highlighted by its interaction with other proteins including FEZ1 84 and Nudel. [85] [86] [87] [88] FEZ1 is thought to function in axon outgrowth and is associated with DISC1 at axon growth cones, suggesting a requirement for DISC1 in neurite extension, a process critical for synaptic connectivity. 84 Interaction between DISC1 and Nudel suggests an additional significant neurodevelopmental role because Nudel complexes with LIS1, a molecule required for neuronal migration and cortical lamination. LIS1 mutations are a major cause of lissencephaly, a neurodevelopmental condition with variable degrees of cognitive impairment.
IMPLICATIONS FOR THE GENETICS OF NEUROPSYCHIA-TRIC ILLNESSES
In light of the data presented here, the authors suggest that karyotype screening should be implemented as a potentially fruitful adjunct to any academic project involving the collection of patient samples. In addition, however, the low frequency of 'hits' would probably make it uneconomical in the context of routine healthcare provision, except in instances where strong family history is evident. The number of candidate genes identified by cytogenetic analysis has increased rapidly since the release of the human genome sequence, but the functional exploration of these candidates is lagging some way behind, perhaps due to the lack of positive association studies in many cases or the perceived limitations attached to results derived from single individuals. However, as methods for the detection of submicroscopic chromosomal alterations are becoming more rapid and refined, the analysis of unique gene disruptions in individuals with complex phenotypes may be an important source of information about the causes of common forms of these conditions.
Common disorders with a strong genetic basis, including psychiatric illnesses can be modelled as being due to additive or interactive effects of functionally important, relatively common genetic variants that have incomplete penetrance and small effects at the population level (odds ratio o2): referred to as the 'common disease, common variant' hypothesis. 2, 89 Another situation, illustrated by mutations in the APC gene that causes colorectal polyps, is that a number of rare mutations of high penetrance at different sites in a single gene have an additive effect in causing disease. 90 Similar rare variants may be typical in many complex disorders including mental disease. 91 A third possibility is locus heterogeneity, illustrated by the genetic basis of nonsyndromic deafness, where the phenotype is caused by a mutation with high penetrance in one of very many genes. 92 The genes included in Table 1 in this study are possibly illustrative of the locus heterogeneity model.
The uncertainty over the mode of inheritance of neuropsychiatric disorders has not yet been resolved. Schizophrenia and bipolar disorder are clearly not simple Mendelian disorders but equally the quantitative trait model may not explain the pattern of illness found in many families. The evidence from cytogenetic studies such as the t(1;11) family in which DISC1 is disrupted is consistent with a single gene effect with variable penetrance increasing risk of illness in individuals up to 50-fold. Our understanding of Alzheimers disease can serve as a useful comparator: genes of major effect accounting for rare familial forms of the disease (PSEN1, PSEN2 and APP) coexist with more common risk factors present in the population such as APOE4. If breakpoint genes correspond to the former, then it is clear that much useful biological information is waiting to be gained from their study.
